Table: Rohto - 9-MTH group results

Rohto Pharmaceutical

10/02/2022 06:00

Feb 10 (Reuters)- 
             Rohto Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2021        Dec 31, 2020     Mar 31, 2022 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              144.02              129.61           195.00    
                                       (-6.2 pct)       (+7.6 pct)  
  Operating           23.55               16.45            28.00    
                                       (-9.2 pct)       (+21.8 pct) 
  Recurring           23.74               16.82            28.00    
                                       (-6.9 pct)       (+17.1 pct) 
  Net                 16.93               10.71            19.50    
                                       (-14.8 pct)      (+16.5 pct) 
  EPS              148.45 yen           93.87 yen       170.95 yen  
  EPS Diluted      148.02 yen           93.60 yen                   
  Ann Div                               28.00 yen        36.00 yen  
  -Q2 div           15.00 yen           13.00 yen                   
  -Q4 div                               15.00 yen        21.00 yen  
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T